HLA-G inhibits the transendothelial cell migration of human NK cells: a strategy for inhibiting xenograft rejection.
Dorling
A
A
Department of Immunology, Imperial College School of Medicine, Hammersmith Hospital, London, UK.
Monk
N
N
Lechler
R
R
D000818:Animals; D002461:Cell Line, Transformed; D002465:Cell Movement; D004730:Endothelium, Vascular / Q000502:physiology*; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D006680:HLA Antigens / Q000502:physiology*; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000502:physiology*; D006801:Humans; D007694:Killer Cells, Natural / Q000502:physiology*; D011994:Recombinant Proteins / Q000276:immunology; D013552:Swine; D014162:Transfection; D014183:Transplantation, Heterologous / Q000276:immunology*
D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; D011994:Recombinant Proteins